SAFE, PRIVATE & SECURE
Your iOPharma™ account is password protected and safe from prying eyes. All iOPharma™ plans include SSL security - the same as online banks. Your data is secure.
SUPPORT FOR MULTIPLE LANGUAGES
iOPharma™ will be translated into Chinese, Spanish, French, German and Portuguese. More languages will be added to this list as time goes on. To find out more about the translations, please contact us at info@io-pharma.com.
FREE REGISTRATION
Whether you’re a buyer or a supplier the iOPharma™ platform will benefit your organisation.
REGISTER NOW
Foreign Materials in Pharmaceuticals
Despite the best efforts of manufacturers to produce to the highest standards, there are a number...
Read moreGilead's HCV drug gets green light in USA
Regulators in the USA have given the green light to Gilead Sciences' Sovaldi, the first drug that...
Read morePfizer to give data to participants in its studies
As the debate on data transparency continues, Pfizer has updated its policy "that will simplify and...
Read moreThe Medicines Company snaps up antibiotics firm Rempex
The Medicines Company has snapped up antibiotics group Rempex in a deal potentially worth around...
Read morePfizer to give data to participants in its studies
As the debate on data transparency continues, Pfizer has updated its policy "that will simplify and...
Read moreGlenmark Announces Appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API Business
Glenmark Pharmaceuticals announces the appointment of Mr. Philip Andrew Gioia (Phil) as President...
Read moreHikma latest to ink long-term prefilled deal with 'ambitious' Unilife
Unilife has signed a $40m long-term supply agreement with Hikma and says it is committed to...
Read moreNovartis Foundation launches new leprosy strategy at symposium on disease elimination
Today's symposium of the Novartis Foundation for Sustainable Development (NFSD) convenes experts to...
Read moreCan Pharma Defy Gravity at the Patent Cliff?
Generic-drug competition has become increasingly aggressive, especially in an environment where...
Read moreIsis gets $3m from GSK for PhI trial of antiviral
Isis Pharmaceuticals has kicked off a Phase I study of an antiviral candidate partnered with GSK,...
Read more